Healthcare provider profile · identity verified

Jeffrey David Millman, MD

Family Practice · SPARKS, NV · NPI 1316010846

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	216	65
Levothyroxine Sodium	Levothyroxine Sodium	211	54
Alprazolam	Alprazolam	159	41
Losartan Potassium	Losartan Potassium	131	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	16
Atorvastatin Calcium	Atorvastatin Calcium	106	34
Potassium Chloride	Potassium Chloride	102	31
Gabapentin	Gabapentin	84	20
Omeprazole	Omeprazole	73	23
Hydrochlorothiazide	Hydrochlorothiazide	71	22
Tramadol Hcl	Tramadol Hcl	68	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	63	21
Zolpidem Tartrate	Zolpidem Tartrate	63	suppressed
Synthroid	Levothyroxine Sodium	59	16
Furosemide	Furosemide	56	17
Metformin Hcl Er	Metformin Hcl	56	18
Amlodipine Besylate	Amlodipine Besylate	47	17
Diazepam	Diazepam	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	suppressed
Lorazepam	Lorazepam	46	suppressed
Glipizide Er	Glipizide	45	13
Metoprolol Succinate	Metoprolol Succinate	45	19
Lisinopril	Lisinopril	43	13
Rosuvastatin Calcium	Rosuvastatin Calcium	42	13
Clonazepam	Clonazepam	38	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	38	12
Sertraline Hcl	Sertraline Hcl	36	12
Eliquis	Apixaban	35	suppressed
Trazodone Hcl	Trazodone Hcl	35	11
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	11
Albuterol Sulfate Hfa	Albuterol Sulfate	30	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Metformin Hcl	Metformin Hcl	30	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Finasteride	Finasteride	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Memantine Hcl Er	Memantine Hcl	25	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	22	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Cefdinir	Cefdinir	19	15
Estradiol (Once Weekly)	Estradiol	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Estradiol	Estradiol	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Glipizide	Glipizide	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Digoxin	Digoxin	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Mupirocin	Mupirocin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error